Jeil Pharma Holdings Inc (KRX:002620)
8,170.00
-80.00 (-0.97%)
At close: Jun 2, 2025, 3:30 PM KST
Jeil Pharma Holdings Revenue
Jeil Pharma Holdings had revenue of 182.04B KRW in the quarter ending March 31, 2025, a decrease of -3.59%. This brings the company's revenue in the last twelve months to 773.03B, down -1.63% year-over-year. In the year 2024, Jeil Pharma Holdings had annual revenue of 779.82B, down -3.01%.
Revenue (ttm)
773.03B
Revenue Growth
-1.63%
P/S Ratio
0.16
Revenue / Employee
20.89B
Employees
37
Market Cap
126.19B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 779.82B | -24.22B | -3.01% |
Dec 31, 2023 | 804.04B | 11.08B | 1.40% |
Dec 31, 2022 | 792.96B | 30.40B | 3.99% |
Dec 31, 2021 | 762.57B | 571.30M | 0.07% |
Dec 31, 2020 | 762.00B | 30.19B | 4.13% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |